期刊文献+

长期服用氨己烯酸引起视野缺损的自然进程

The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication
下载PDF
导出
摘要 Purpose. To determine the natural history of visual field defects in a group of patients known to haveVigabatrin-associated changes who elected to continue themedication because of good seizure control. Methods. All patients taking Vigabatrin alone or in combination with other antiepileptic drugs for at least 5 years (range 5- 12 years) were entered into a visual surveillance programme. Patients were followed up at 6- monthly intervals for not less than 18 months (range 18- 43 months). In all, 16 patients with unequivocal defects continued the medication. Following already published methodology (Eye 2002; 16;567- 571) monocular mean radial degrees (MRDs) to the I/4e isopter on Goldmann perimetry was calculated for the right eye at the time of discovery of a visual field defect and again after not less than 18 months follow-up. Results. Mean right eye MRD at presentation was 36.98° (range 22.25- 51.0), compared to 38.40° (range 22.5- 49.75) after follow-up; P=0.338 unpaired t-test. Only one patient demonstrated a deterioration in visual field during the study period and discontinued treatment. Conclusion. Established visual field defects presumed to be due to Vigabatrin therapy did not usually progress in spite of continuing use of the medication. These data give support to the hypothesis that the pathogenesis of Vigabatrin-associated visual field defects may be an idiosyncratic adverse drug reaction rather than dose-dependent toxicity. Purpose. To determine the natural history of visual field defects in a group of patients known to haveVigabatrin-associated changes who elected to continue themedication because of good seizure control. Methods. All patients taking Vigabatrin alone or in combination with other antiepileptic drugs for at least 5 years (range 5- 12 years) were entered into a visual surveillance programme. Patients were followed up at 6- monthly intervals for not less than 18 months (range 18- 43 months). In all, 16 patients with unequivocal defects continued the medication. Following already published methodology (Eye 2002; 16;567- 571) monocular mean radial degrees (MRDs) to the I/4e isopter on Goldmann perimetry was calculated for the right eye at the time of discovery of a visual field defect and again after not less than 18 months follow-up. Results. Mean right eye MRD at presentation was 36.98° (range 22.25- 51.0), compared to 38.40° (range 22.5- 49.75) after follow-up; P=0.338 unpaired t-test. Only one patient demonstrated a deterioration in visual field during the study period and discontinued treatment. Conclusion. Established visual field defects presumed to be due to Vigabatrin therapy did not usually progress in spite of continuing use of the medication. These data give support to the hypothesis that the pathogenesis of Vigabatrin-associated visual field defects may be an idiosyncratic adverse drug reaction rather than dose-dependent toxicity.
出处 《世界核心医学期刊文摘(眼科学分册)》 2005年第6期35-35,共1页 Digest of the World Core Medical Journals:Ophthalmology
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部